Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gon-4-like protein (GON4L) is a nuclear protein encoded by the GON4L gene in humans and other vertebrates, highly conserved among species[6][1]. It functions primarily as a transcriptional co-repressor, forming large nuclear complexes that include the transcription factor YY1, co-repressor SIN3A, and histone deacetylase HDAC1, thereby regulating gene expression through chromatin modification and gene repression[2][3]. GON4L is essential for B cell differentiation and broader developmental processes including hematopoiesis and embryogenesis[2][1][7]. It contains specific conserved structural domains such as a paired amphipathic helix (PAH), myb-like domain, and a SANT domain, which mediate protein-protein interactions critical for its functions[2][5]. Mutations in GON4L are associated with developmental syndromes such as Li-Takada-Miyake syndrome, muscle and neurodevelopmental disorders, but it is not currently considered a druggable target or receptor, and no small molecule inhibitors or clinical therapeutics are directed at GON4L as of now[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gon-4-like protein (GON4L).